ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350629; 2) Community: the network communities that were significantly associated with the response to NSC 350629; 3) Molecule: the relationships between components within communities and NSC 350629; 4) MDR: the compounds that were significantly associated with the NSC 350629.

NSC Compound Enrichment Correlation
NSC 736914 Null 0.00397405528023193 0.43850255
NSC 749379 Null 0.00397405528023193 0.56159603
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.00397405528023196 0.46967566
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.00397405528023196 0.37946286
NSC 600301 Null 0.00415748671857516 0.65514798
NSC 135037 Jatrophone 0.00426229108513041 0.85015697
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.00426229108513041 0.85529854
NSC 629595 Null 0.00426229108513043 0.61378955
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.00426229108513043 0.58173279
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.00426229108513043 0.74584953
Total:116  Current:27    [First] [Prev] [Next] [Last]